The pandemic brought a national spotlight to some of the smallest niches of the healthcare system, including specialized biotechnology labs, telemedicine providers, and specialized pharma companies.  Suddenly, the world has called for ubiquitous specialized testing, resumed outpatient services through telemedicine, and cures using new fields of science including immunotherapy.  Healthcare had long been fragmented before the pandemic struck, with providers themselves not fully aware of the entirety of the healthcare system, but the pandemic exacerbated this fragmentation, and the response proved that third parties were needed to coordinate niche areas of the healthcare system not needed previously to serve the entire world on a massive scale.  Without the intervention of third parties, many important groups of patients, especially among special populations, have been failed by the response, resulting in massive hot spot/red zone statistics within these demographics.

Boston Mantra LLC specializes in third party coordination of the healthcare system, especially niche areas of biotechnology, healthcare delivery, and pharma.  Utilizing the combined clinician- industry expertise of our consultants, Boston Mantra works with all stakeholders to achieve successful outcomes in testing, tracing, and treatment to the greatest multi-disciplinary extent possible.

The Pandemic brought out a very public debate on the relative merit of various therapeutics, but also an interesting fascet once mostly limited to infectious disease therapeutics, infectious disease sensitivity.  The most effective way to determine the efficacy of therapeutics is through personalized sensitivity testing, which is not possible not only in antimicrobials, but for a wide range of therapeutics by assessing the relative genetic pattern of CYP450 synthesis.  Despite the demand for efficacy studies at an individual level, the genetic profiles, much less personalized  genetic profile sequences have yet to be developed for many therapeutics.  As clinicnas debate macro-evel statistical studies to compare medications and try varying doses based on subjective experience in other patients, many patients die or fail to get timely care with the right medicine due to the time it takes to titrate toward efficacy.

Boston Mantra specializes in consultancy in developing companion diagnostics including utilizing a variety of specialty genetic databases, expanding testing capacity through laboratory director QA-QC support services, and helping las to take advantage of inter-state regulatory relief to expand across state lines into new market territory.  Utilizing over 30 years of biotechnology industry level expertise, Boston Mantra consultants are uniquely poised to develop industry standard biotechnological tests, assist labs get accreditation, consult on biotech innovation to develop business, and train professionals in advanced whole genome testing.

The pandemic brought a national spotlight to some of the smallest niches of the healthcare system, including specialized biotechnology labs, telemedicine providers, and specialized pharma companies.  Suddenly, the world has called for ubiquitous specialized testing, resumed outpatient services through telemedicine, and cures using new fields of science including immunotherapy.  Healthcare had long been fragmented before the pandemic struck, with providers themselves not fully aware of the entirety of the healthcare system, but the pandemic exacerbated this fragmentation, and the response proved that third parties were needed to coordinate niche areas of the healthcare system not needed previously to serve the entire world on a massive scale.  Without the intervention of third parties, many important groups of patients, especially among special populations, have been failed by the response, resulting in massive hot spot/red zone statistics within these demographics.

The pandemic highlighted the many gaps in preparedness the healthcare system suffered including shortages of PPE, ventilators, and staff at all levels of the healthcare system.  These shortages were exacerbated by revenue constraints caused by closure of outpatient departments, failure of supply chains to meet an enormously increased demand for critical care supplies, and a failure of under-staffed facilities to meet a rising demand for complex cases.  Both healthcare provider and patient alike were left behind by these shortages, exposing healthcare providers or forcing them to lower occupational safety standards of PPE, forcing patients to undergo treatment with shared facilities, and subjecting patients to overcrowded therapeutic relationships.  The failure of healthcare leadership to prepare for the pandemic, as well as many other possible disasters, has opened the eyes of the public to this oversight.

Boston mantra LLC specializes in disaster and pandemic preparedness from both a public health and public safety standpoint.  Utilizing unique expertise, Boston Mantra aims to shore up healthcare facilities in one of the three main areas every healthcare facility must address successfully in order to achieve its mission, healthcare certification or accreditation, healthcare strategy as well as workforce development, and industry economic analysis.